Kanuma Approved for Rare Missing-Enzyme Disease

TUESDAY, Dec. 8, 2015 — Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for a rare but often-deadly disease caused by an enzyme deficiency.
People with Lal deficiency, also known as Wolman…
Source: Topamax